Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Experience of a 40-day (6 week) LMWH treatment for isolated distal deep vein thrombosis.

Asonitis K, Charvalos E, Lambert C, Hermans C.

J Thromb Thrombolysis. 2020 Mar 18. doi: 10.1007/s11239-020-02089-5. [Epub ahead of print]

PMID:
32189191
2.

Health risk behaviors among high school and university adolescent students.

Tsitsimpikou C, Tsarouhas K, Vasilaki F, Papalexis P, Dryllis G, Choursalas A, Spandidos DA, Tsatsakis A, Charvalos E, Bacopoulou F.

Exp Ther Med. 2018 Oct;16(4):3433-3438. doi: 10.3892/etm.2018.6612. Epub 2018 Aug 17.

3.

Magnetic nanoparticle-enhanced PCR for the detection and identification of Staphylococcus aureus and Salmonella enteritidis.

Houhoula D, Papaparaskevas J, Zatsou K, Nikolaras N, Malkawi HI, Mingenot-Leclercq MP, Konteles S, Koussisis S, Tsakris A, Charvalos E.

New Microbiol. 2017 Jul;40(3):165-169. Epub 2017 May 17.

4.

Molecular detection of potential sexually transmitted pathogens in semen and urine specimens of infertile and fertile males.

Abusarah EA, Awwad ZM, Charvalos E, Shehabi AA.

Diagn Microbiol Infect Dis. 2013 Dec;77(4):283-6. doi: 10.1016/j.diagmicrobio.2013.05.018. Epub 2013 Sep 29.

PMID:
24079950
5.

The shotgun proteomic study of the human ThinPrep cervical smear using iTRAQ mass-tagging and 2D LC-FT-Orbitrap-MS: the detection of the human papillomavirus at the protein level.

Papachristou EK, Roumeliotis TI, Chrysagi A, Trigoni C, Charvalos E, Townsend PA, Pavlakis K, Garbis SD.

J Proteome Res. 2013 May 3;12(5):2078-89. doi: 10.1021/pr301067r. Epub 2013 Apr 22.

PMID:
23510160
6.

High level of heterogeneity among Listeria monocytogenes isolates from clinical and food origin specimens in Greece.

Houhoula DP, Peirasmaki D, Konteles SJ, Kizis D, Koussissis S, Bratacos M, Poggas N, Charvalos E, Tsakris A, Papaparaskevas J.

Foodborne Pathog Dis. 2012 Sep;9(9):848-52. doi: 10.1089/fpd.2012.1187. Epub 2012 Aug 10.

PMID:
22880958
7.

Climate changes, environment and infection: facts, scenarios and growing awareness from the public health community within Europe.

Bezirtzoglou C, Dekas K, Charvalos E.

Anaerobe. 2011 Dec;17(6):337-40. doi: 10.1016/j.anaerobe.2011.05.016. Epub 2011 Jun 2.

PMID:
21664978
8.

Prevalence and characterization of class 1 integrons in Escherichia coli of poultry and human origin.

Vasilakopoulou A, Psichogiou M, Tzouvelekis L, Tassios PT, Kosmidis C, Petrikkos G, Roma ES, Charvalos E, Passiotou M, Avlami A, Daikos GL.

Foodborne Pathog Dis. 2009 Dec;6(10):1211-8. doi: 10.1089/fpd.2009.0281.

PMID:
19735202
9.

Comparison of cytology, colposcopy, HPV typing and biomarker analysis in cervical neoplasia.

Adamopoulou M, Kalkani E, Charvalos E, Avgoustidis D, Haidopoulos D, Yapijakis C.

Anticancer Res. 2009 Aug;29(8):3401-9.

10.

Water-soluble amphotericin B-polyvinylpyrrolidone complexes with maintained antifungal activity against Candida spp. and Aspergillus spp. and reduced haemolytic and cytotoxic effects.

Charvalos E, Tzatzarakis MN, Van Bambeke F, Tulkens PM, Tsatsakis AM, Tzanakakis GN, Mingeot-Leclercq MP.

J Antimicrob Chemother. 2006 Feb;57(2):236-44. Epub 2005 Dec 16.

PMID:
16361329
11.

Value of measuring serum procalcitonin, C-reactive protein, and mannan antigens to distinguish fungal from bacterial infections.

Petrikkos GL, Christofilopoulou SA, Tentolouris NK, Charvalos EA, Kosmidis CJ, Daikos GL.

Eur J Clin Microbiol Infect Dis. 2005 Apr;24(4):272-5.

PMID:
15902534
12.

Could procalcitonin be a predictive biological marker in systemic fungal infections?. Study of 14 cases.

Christofilopoulou S, Charvalos E, Petrikkos G.

Eur J Intern Med. 2002 Dec;13(8):493-495.

PMID:
12446193
13.

New nystatin polymeric complexes and their in vitro antifungal evaluation in a model study with Fusarium oxysporum.

Charvalos E, Tsatsakis A, Tzatzarakis M, Dolapsakis G, Stiakakis J.

Mycopathologia. 2002;153(1):15-9.

PMID:
11913760
14.

Controlled release of water-soluble polymeric complexes of sorbic acid with antifungal activities.

Charvalos E, Tzatzarakis M, Tsatsakis A, Petrikkos G.

Appl Microbiol Biotechnol. 2001 Dec;57(5-6):770-5.

PMID:
11778892
15.

Antimicrobial activity of argon fluoride (ArF) excimer laser on gram-negative bacteria.

Charvalos E, Karoutis A.

Appl Microbiol Biotechnol. 2001 Jul;56(1-2):243-8.

PMID:
11499938
16.

Comparison of in vitro activities of amphotericin, clotrimazole, econazole, miconazole, and nystatin against Fusarium oxysporum.

Tzatzarakis MN, Tsatsakis AM, Charvalos E, Vakalounakis D.

J Environ Sci Health B. 2001 May;36(3):331-40.

PMID:
11411855
17.

Epidemiological study of brucellosis in eight Greek villages using a computerised mapping programme.

Hadjichristodoulou C, Papatheodorou C, Soteriades E, Panagakos G, Kastritis I, Goutziana G, Charvalos E, Tselentis Y.

Eur J Epidemiol. 1999 Aug;15(7):671-80.

PMID:
10543359
18.
19.

Evidence for an efflux pump in multidrug-resistant Campylobacter jejuni.

Charvalos E, Tselentis Y, Hamzehpour MM, Köhler T, Pechere JC.

Antimicrob Agents Chemother. 1995 Sep;39(9):2019-22.

Supplemental Content

Loading ...
Support Center